Skip to content
ClearheadLab
Menu

Evidence review

Does NAD+ Help Brain Fog?

Does NAD+ actually lift brain fog? The short answer is: no proven benefit. Here's what the human trials really found, sourced and honest.

By Nadia Brooks, Cognitive Health Editor

Short answer: there is **no proven cognitive benefit** from NAD+ for brain fog. NAD+ precursors can reliably raise the NAD+ level in your blood, but raising that number has not been shown to lift fog, sharpen focus, or improve memory in people. This page lays out exactly what the human evidence says — and where it stops.

The Claim vs. What's Been Demonstrated

NAD+ is a coenzyme central to how cells make energy, so the *idea* that more NAD+ means more mental energy has surface appeal. There's real biology underneath it: NAD+ metabolism becomes deregulated in aging and diseased brain cells, which is why researchers find the molecule worth studying for cognition in the first place1. The problem is the leap from "NAD+ matters for cell metabolism" to "supplementing NAD+ clears brain fog." That leap hasn't been demonstrated in humans — a mechanism is a reason to investigate, not a result.

It is well established that oral precursors raise the biomarker. A randomized trial of an oral NMN formulation confirmed it increases circulating NAD+ and its metabolome in middle-aged and older adults2. But that trial measured NAD+ pharmacology — not focus, not memory, not "fog." Raising NAD+ is the easy part to prove; improving cognition is the part that keeps failing to show up. That distinction is the whole story here, and it's worth keeping front of mind whenever a product cites a "NAD+ increase" as if it were a cognitive result.

The Trial That Settles the Core Question

The most relevant human study is a randomized, placebo-controlled trial of nicotinamide riboside (NR) in older adults with mild cognitive impairment. Oral NR did raise NAD+ in the body — and **cognition did not improve** versus placebo3. That's the cleanest test available of the exact promise behind NAD+ products: the biomarker moved, the thinking did not. When the cleanest, best-designed study of a claim returns a null result, that's the data point that should carry the most weight — not the testimonials.

People sometimes counter with an Alzheimer's trial that reported cognitive improvement. But that study used a **multi-ingredient metabolic-activator cocktail** — NR combined with L-serine, N-acetylcysteine, and L-carnitine tartrate4. You cannot credit NAD+/NR alone for any effect, and results in Alzheimer's patients don't transfer to a healthy person dealing with everyday foggy thinking. A confounded trial in a disease population is the opposite of evidence that a precursor sharpens a healthy mind.

What About Energy and Fatigue?

Maybe NAD+ doesn't fix "cognition" on tests but helps subjective energy or mental fatigue? The data there are **mixed and weak**. A 12-week trial of oral NMN in older Japanese adults found only modest or subgroup-specific hints on fatigue and physical performance — not a robust, reliable cognitive-energy benefit5. Inconsistent signals in small trials are exactly what you'd expect from something that isn't doing much; if there were a strong, reliable effect on energy, it would tend to show up cleanly rather than flickering in and out of subgroups.

Why the Biomarker-Cognition Gap Matters

It's tempting to assume that if a supplement moves a number in your blood, it must be "working." But a biomarker is only useful if changing it changes the outcome you care about. NAD+ is a textbook case where the biomarker reliably responds and the clinical outcome — your thinking — does not follow. That's not a quirk of one study; it's the consistent pattern across the human cognition data in this space. Treat "it raised my NAD+" as confirmation the supplement is bioavailable, not as proof it did anything for your focus.

So, Does NAD+ Help Brain Fog?

On current evidence: not in any proven way. Precursors raise NAD+ reliably; the best-controlled cognition trial showed no benefit; the one "positive" trial was a confounded cocktail; and the energy/fatigue data are inconsistent. That's the honest answer, and saying so is what separates an evidence-based read from a sales pitch.

If brain fog is what's bothering you, the higher-yield move is to figure out what's actually driving it. Brain fog is a multifactorial symptom, and sleep is its single strongest, best-evidenced lever — sleep deprivation alone clearly impairs attention, working memory, and processing speed6. Chasing one molecule rarely addresses that. For the broader review of what the NAD+ evidence shows, see the pillar guide, NAD+, Brain Fog & Focus: What the Evidence Shows, and for the full list of common drivers, What Actually Causes Brain Fog?.

Frequently asked questions

Does NAD+ clear brain fog?

There is no proven cognitive benefit. NAD+ precursors reliably raise blood NAD+, but the best-controlled human trial found cognition unchanged despite that rise.

Why do products say NAD+ boosts mental energy?

Because precursors can be shown to raise NAD+ in the blood, which is true. But raising the biomarker is not the same as improving energy or focus, and the human cognitive/energy data are null-to-mixed.

Is there any positive cognition trial?

One Alzheimer's phase-II trial reported improvement, but it used a multi-ingredient cocktail (NR plus L-serine, N-acetylcysteine, L-carnitine tartrate), so the result can't be attributed to NAD+ alone or applied to healthy brain fog.

If not NAD+, what should I look at for brain fog?

Brain fog is a multifactorial symptom. Sleep is the strongest evidence-based lever, alongside identifying and treating underlying causes like stress, post-viral illness, or medical conditions.

References

  1. Kolotyeva NA, Groshkov AA, Rozanova NA, et al. (2024). Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells. Biomolecules. 2024;14(12):1556. https://doi.org/10.3390/biom14121556
  2. Pencina KM, Lavu S, Dos Santos M, Beleva YM, Cheng M, Livingston D, Bhasin S (2023). MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of beta-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults. The Journals of Gerontology. Series A. 2023;78(1):90-96. https://doi.org/10.1093/gerona/glac049
  3. Orr ME, Kotkowski E, Ramirez P, Bair-Kelps D, Liu Q, Brenner C, et al. (2024). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. 2024;46(1):665-682. https://doi.org/10.1007/s11357-023-00999-9
  4. Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, et al. (2023). Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. Translational Neurodegeneration. 2023;12(1):4. https://doi.org/10.1186/s40035-023-00336-2
  5. Kim M, Seol J, Sato T, Fukamizu Y, Sakurai T, Okura T (2022). Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients. 2022;14(4):755. https://doi.org/10.3390/nu14040755
  6. Khan MA, Al-Jahdali H (2023). The consequences of sleep deprivation on cognitive performance. Neurosciences (Riyadh). 2023;28(2):91-99. https://doi.org/10.17712/nsj.2023.2.20220108

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.